Article

Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional study

2023-08-09

Abstract excerpt

<h4>Background: </h4> The difference in prevalence and systemic inflammatory (SI) status from non-alcoholic fatty liver disease (NAFLD) to newly defined metabolic dysfunction-associated fatty liver disease (MAFLD) was less reported. Therefore, we estimated the prevalence and summarized the systemic inflammation levels of MAFLD and NAFLD in a general population from Southern China to explore the potential effect of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1e601f80-e3f8-50a1-b16f-f7bed0e19a02
DOI: 10.21203/rs.3.rs-3231080/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional studyDOI 10.21203/rs.3.rs-3231080/v1Read

A comparison of NAFLD and MAFLD diagnostic criteria in contemporary urban healthy adults in ChinaSemantic proximity Read

Epidemiology of alcoholic and nonalcoholic fatty liver disease in China.Semantic proximity Read

External Validation and Comparison of Simple Tools to Screen for Nonalcoholic Fatty Liver disease in Chinese community populationSemantic proximity Read

Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and BeyondSemantic proximity Read

Comparison of Metabolic Dysfunction-Associated Fatty Liver Disease with Non-Alcoholic Fatty Liver Disease in Identifying Cardiovascular Risk in Chinese Individuals with Rheumatoid ArthritisSemantic proximity Read

Elevated TG/HDL-C Ratio as a Marker for NAFLD Risk and Severity: Insights from a Cross-Sectional AnalysisSemantic proximity Read

Natural History of NAFLDSemantic proximity Read

The Health Impact of MAFLD, a Novel Disease Cluster of NAFLD, Is Amplified by the Integrated Effect of Fatty Liver Disease-Related Genetic Variants.Semantic proximity Read

Prevalence of Significant and Advanced Hepatic Fibrosis in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)Semantic proximity Read

Non-alcoholic fatty liver disease: what the clinician needs to know.Semantic proximity Read

Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated alcohol‑related liver disease represent distinct clinical phenotypes and fibrosis risks: insights from a population-based Polish cohort.Semantic proximity Read

Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal studySemantic proximity Read